These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 191950)

  • 61. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
    Farndale RW; Winkler AB; Martin BR; Barnes MJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclic AMP does not inhibit collagen-induced platelet signal transduction.
    Smith JB; Dangelmaier C; Selak MA; Ashby B; Daniel J
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):889-92. PubMed ID: 1375452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of platelet adenylate cyclase by ADP.
    Mellwig KP; Jakobs KH
    Thromb Res; 1980 Apr 1-15; 18(1-2):7-17. PubMed ID: 6250246
    [No Abstract]   [Full Text] [Related]  

  • 64. Platelet-vessel-wall interactions: experiences with von Willebrand platelets.
    Barnhart MI; Wilkins RM; Lusher JM
    Ann N Y Acad Sci; 1981; 370():154-78. PubMed ID: 6791541
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Receptor- and phorbol-ester-mediated redistribution of protein kinase C in human platelets. Evidence that aggregation promotes degradation of protein kinase C.
    Wheeler-Jones CP; Patel Y; Kakkar VV; Krishnamurthi S
    Biochem J; 1989 Nov; 263(3):969-72. PubMed ID: 2597139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.
    Weiss HJ; Turitto VT; Baumgartner HR
    J Lab Clin Med; 1978 Nov; 92(5):750-64. PubMed ID: 309498
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Platelet physiology and abnormalities of platelet function (first of two parts).
    Weiss HJ
    N Engl J Med; 1975 Sep; 293(11):531-41. PubMed ID: 168489
    [No Abstract]   [Full Text] [Related]  

  • 69. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of aggregating agents on oxidative metabolism of rabbit platelets.
    McElroy FA; Kinlough-Rathbone RL; Ardlie NG; Packham MA; Mustard JF
    Biochim Biophys Acta; 1971 Nov; 253(1):64-77. PubMed ID: 4331274
    [No Abstract]   [Full Text] [Related]  

  • 71. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.
    Lages B; Weiss HJ
    Thromb Haemost; 1997 Feb; 77(2):376-82. PubMed ID: 9157599
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyclic AMP and platelet function.
    Salzman EW
    N Engl J Med; 1972 Feb; 286(7):358-63. PubMed ID: 4333462
    [No Abstract]   [Full Text] [Related]  

  • 73. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.
    Geiger J; Nolte C; Butt E; Sage SO; Walter U
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1031-5. PubMed ID: 1310537
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment.
    Turitto VT; Weiss HJ; Baumgartner HR
    J Lab Clin Med; 1983 Oct; 102(4):551-64. PubMed ID: 6413629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A USEFUL PHOTOMETRIC TEST FOR THE DIAGNOSIS OF VON WILLEBRAND'S DISEASE.
    VAINER H; CAEN JP
    J Clin Pathol; 1964 Mar; 17(2):191-3. PubMed ID: 14149949
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets.
    Rozenberg MC; Walker CM
    Br J Haematol; 1973 Apr; 24(4):409-18. PubMed ID: 4351761
    [No Abstract]   [Full Text] [Related]  

  • 79. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD
    Ann Clin Lab Sci; 1989; 19(3):184-9. PubMed ID: 2499240
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from alpha-granules to the cell surface.
    Heijnen HF; Oorschot V; Sixma JJ; Slot JW; James DE
    J Cell Biol; 1997 Jul; 138(2):323-30. PubMed ID: 9230074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.